company background image
BRM logo

BioRem TSXV:BRM Stock Report

Last Price

CA$3.14

Market Cap

CA$47.6m

7D

2.3%

1Y

210.9%

Updated

20 Dec, 2024

Data

Company Financials

BRM Stock Overview

A clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). More details

BRM fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

BioRem Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioRem
Historical stock prices
Current Share PriceCA$3.14
52 Week HighCA$3.39
52 Week LowCA$0.95
Beta0.92
1 Month Change6.80%
3 Month Change28.69%
1 Year Change210.89%
3 Year Change256.82%
5 Year Change685.00%
Change since IPO-8.99%

Recent News & Updates

Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Oct 11
Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Recent updates

Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Oct 11
Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

Apr 19
Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

Apr 12
BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Jan 25
BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Is BioRem (CVE:BRM) Using Too Much Debt?

Aug 26
Is BioRem (CVE:BRM) Using Too Much Debt?

Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

Mar 23
Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

BioRem (CVE:BRM) Could Easily Take On More Debt

Aug 25
BioRem (CVE:BRM) Could Easily Take On More Debt

These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

May 20
These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Jan 26
Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Nov 23
Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Shareholder Returns

BRMCA Commercial ServicesCA Market
7D2.3%1.2%-2.6%
1Y210.9%28.3%15.2%

Return vs Industry: BRM exceeded the Canadian Commercial Services industry which returned 28.5% over the past year.

Return vs Market: BRM exceeded the Canadian Market which returned 15% over the past year.

Price Volatility

Is BRM's price volatile compared to industry and market?
BRM volatility
BRM Average Weekly Movement8.0%
Commercial Services Industry Average Movement6.6%
Market Average Movement8.1%
10% most volatile stocks in CA Market17.3%
10% least volatile stocks in CA Market2.9%

Stable Share Price: BRM has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: BRM's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990n/aDerek Webbwww.biorem.biz

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). The company offers biofilters; biotrickling filters; multi-stage synergy systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It sells its products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK.

BioRem Inc. Fundamentals Summary

How do BioRem's earnings and revenue compare to its market cap?
BRM fundamental statistics
Market capCA$47.55m
Earnings (TTM)CA$5.20m
Revenue (TTM)CA$40.31m

9.7x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BRM income statement (TTM)
RevenueCA$40.31m
Cost of RevenueCA$27.45m
Gross ProfitCA$12.87m
Other ExpensesCA$7.67m
EarningsCA$5.20m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.32
Gross Margin31.92%
Net Profit Margin12.90%
Debt/Equity Ratio25.8%

How did BRM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 08:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioRem Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution